文献速递关节外科

全髋与全膝关节置换术后静脉血栓栓塞发生率是否下降

Have Venous Thromboembolism Rates Decreased in Total Hip and Knee Arthroplasty?
PubMed 文献 · J Arthroplasty · 2019-08-29

基于美国外科医师学会NSQIP数据库2008至2016年363530例全髋或全膝关节置换患者,分析30天静脉血栓栓塞、深静脉血栓、肺栓塞及全因死亡率的年度趋势。全膝关节置换患者静脉血栓栓塞和深静脉血栓发生率较2008年下降,全髋关节置换患者各结局无显著变化。作者指出需进一步研究以确定个体化预防方案。

要点

  • 全膝关节置换术后30天静脉血栓栓塞总体发生率为1.4%,全髋关节置换为0.6%。
  • 全膝关节置换患者静脉血栓栓塞和深静脉血栓发生率在2009至2016年较2008年下降。
  • 全髋关节置换患者静脉血栓栓塞、深静脉血栓、肺栓塞及死亡率2008至2016年无显著变化。

核心结论

  • 全膝关节置换术后30天静脉血栓栓塞发生率约1/71,全髋关节置换约1/167。
  • 全膝关节置换的静脉血栓栓塞发生率在过去8年下降,全髋关节置换则保持稳定。
  • 作者认为需进一步研究以确定可实现个体化、有效且安全的预防方案。

研究设计与样本

  • 回顾性数据库研究,使用美国外科医师学会国家手术质量改进计划(NSQIP)数据库。
  • 纳入2008至2016年接受全膝关节置换或全髋关节置换的363530例患者。
  • 采用双变量分析评估手术年份与人口学及合并症的关联。
  • 分别构建全髋和全膝的多变量logistic回归模型,以2008年为参照分析2009至2016年趋势。

主要发现

  • 全髋关节置换总体静脉血栓栓塞、深静脉血栓、肺栓塞和死亡率分别为0.6%、0.4%、0.3%和0.2%。
  • 全髋关节置换多变量回归显示2008至2016年静脉血栓栓塞、深静脉血栓、肺栓塞和死亡率无显著变化(P > .05)。
  • 全膝关节置换总体静脉血栓栓塞、深静脉血栓、肺栓塞和死亡率分别为1.4%、0.9%、0.6%和0.1%。
  • 全膝关节置换多变量回归显示2009至2016年静脉血栓栓塞和深静脉血栓较2008年下降(P < .05)。
  • 全膝关节置换2016年肺栓塞显著下降(P = .002),死亡率无显著变化(P > .05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出需进一步研究以确定可实现个体化、有效且安全的预防方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) is a major cause of morbidity, mortality, and healthcare costs in arthroplasty patients. In an effort to reduce VTEs, numerous strategies and guidelines have been implemented, but their impact remains unclear. The purpose of this study is to compare annual trends in 30-day VTE, deep vein thrombosis (DVT), pulmonary embolism (PE), and all-cause mortality in (1) total hip arthroplasty (THA) and (2) total knee arthroplasty (TKA). METHODS: The American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database identified 363,530 patients who received a TKA or THA from 2008 to 2016. Bivariate analysis was performed to assess the association between the year in which surgery was performed and demographics and comorbidities. Bimodal multivariate logistic regression models for THA and TKA were developed for 2009-2016 using 2008 as a reference. RESULTS: Overall incidence of VTE, DVT, PE, and mortality for THA were 0.6%, 0.4%, 0.3%, and 0.2%, respectively. Based off of multivariate regression VTE, DVT, PE, and mortality rates have shown no significant (P > .05) change from 2008 to 2016 in THA patients. Overall incidence of VTE, DVT, PE, and mortality for TKA were 1.4%, 0.9%, 0.6%, and 0.1%, respectively. Multivariate regression revealed reductions when compared to 2008 for VTEs and DVTs from 2009 to 2016 (P < .05) for TKA patients. A significant reduction in PEs (P = .002) was discovered for 2016, while no significant change was observed in mortality (P > .05). CONCLUSION: Approximately 1 in 71 patient undergoing TKA, and 1 in 167 undergoing THA developed a VTE within 30 days after surgery. Our study demonstrated that VTE incidence rates have decreased in TKA, while remaining stable in THA over the past 8 years. Further research to determine the optimal prophylaxis algorithm that would allow for a personalized, efficacious, and safe thromboprophylaxis regimen is needed. LEVEL OF EVIDENCE: III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Warren JA, Sundaram K, Anis HK, et al. Have Venous Thromboembolism Rates Decreased in Total Hip and Knee Arthroplasty? J Arthroplasty. 2019. PMID: 31530463. doi:10.1016/j.arth.2019.08.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。